• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Medical and Pediatric Oncology: The Official Journal of the American Association for Cancer Education >Totally implantable central venous access devices for paediatric oncology patients.
【24h】

Totally implantable central venous access devices for paediatric oncology patients.

机译：小儿肿瘤科患者的完全可植入的中心静脉通路设备。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

BACKGROUND: Totally implantable central venous access devices (ports) have been available for over 10 years but have not achieved widespread use in paediatric oncology patients. We reviewed our experience with these devices over 9 years to assess their safety and acceptability. PROCEDURE: We conducted a retrospective review of insertion technique and reasons for removal of all ports placed in paediatric oncology patients in this hospital between 1989 and 1996, with follow-up until 1998. Acceptability of both ports and external catheters was assessed by a questionnaire in a subgroup of families attending the oncology clinic. RESULTS: One hundred forty-nine ports were inserted during the study period. The median catheter life was 399 days (4-1,406), with a total of 69,342 catheter days. Sixty-nine percent of ports were removed electively at the end of treatment; 8% required removal because of infection and 5% because of blockage. No ports were accidentally dislodged or damaged. Children experienced significantly less restriction of activity with a port compared to an external catheter and greatly preferred the cosmetic appearance. The need for needle insertion to access the port was not seen as a disadvantage by most families. CONCLUSIONS: Ports can provide satisfactory central venous access for the majority of paediatric oncology patients, with a low risk of line-related complications and a high degree of acceptability to children and their parents. Copyright 1999 Wiley-Liss, Inc.
机译：背景：完全可植入的中心静脉通路设备（端口）已经使用了10多年，但尚未在儿科肿瘤患者中得到广泛使用。我们回顾了我们在这些设备上9年的经验，以评估其安全性和可接受性。程序：我们对1989年至1996年间在该医院的儿科肿瘤患者中放置所有端口的插入技术和原因进行了回顾性回顾，并随访至1998年。肿瘤科的家庭成员。结果：在研究期间插入了149个端口。导管的中位寿命为399天（4-1406），总共为69342天。在治疗结束时有选择性地拆除了69％的端口;由于感染，需要清除8％，而由于堵塞需要清除5％。没有端口被意外移动或损坏。与外部导管相比，儿童对端口的活动限制明显更少，并且非常喜欢外观。大多数家庭并不认为需要插入针头来进入端口。结论：端口可以为大多数儿科肿瘤患者提供满意的中心静脉通路，行相关并发症的风险低，对儿童及其父母的接受程度高。版权所有1999 Wiley-Liss，Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号